alarm-ringing ambulance angle2 archive arrow-down arrow-left arrow-right arrow-up at-sign baby baby2 bag binoculars book-open book2 bookmark2 bubble calendar-check calendar-empty camera2 cart chart-growth check chevron-down chevron-left chevron-right chevron-up circle-minus circle city clapboard-play clipboard-empty clipboard-text clock clock2 cloud-download cloud-windy cloud clubs cog cross crown cube youtube diamond4 diamonds drop-crossed drop2 earth ellipsis envelope-open envelope exclamation eye-dropper eye facebook file-empty fire flag2 flare foursquare gift glasses google graph hammer-wrench heart-pulse heart home instagram joystick lamp layers lifebuoy link linkedin list lock magic-wand map-marker map medal-empty menu microscope minus moon mustache-glasses paper-plane paperclip papers pen pencil pie-chart pinterest plus-circle plus power pushpin question rain reading receipt recycle reminder sad shield-check smartphone smile soccer spades speed-medium spotlights star-empty star-half star store sun-glasses sun tag telephone thumbs-down thumbs-up tree tumblr twitter user users wheelchair write yelp youtube

ClearPath DS-120

Northgate Eye Center, OD, PA is pleased to present to our community the newest technology in diabetic testing available.  We are one of only a few sites in the state, and country, who can provide this cutting edge technology to you.  Welcome the ClearPath DS-120, Diabetes Screener.

The ClearPath screener is a non-invasive test which does a quick 6 second scan of the eye to help the doctor determine your possible risk of diabetes.  This technology, coupled with the other tests we perform here will help preserve your vision and your health.

The DS-120 AVOIDS

  • a painful blood draw
  • the need for fasting prior to testing, and
  • the inconvenience of waiting several days for the test results.

Diabetes is the leading cause of permanent blindness in patients under the age of 75.  With more than 86 million Americans living with pre-diabetes and nearly 90% of them unaware of it, doctors are urging patients to be screened for early risk detection.  Studies show that early detection combined with proper intervention can lower visual complications caused by diabetes by up to 76%.  Because of this, we now have new cutting edge technology that allows us to screen patients for their risk of developing diabetes and it’s part of your eye exam today.

The ClearPath device takes a quick 6 second scan of the natural lens in your eye using light. This FDA approved non invasive test can identify a risk factor for diabetes that no other test can identify more accurately. It is an important tool in the fight against diabetes.